Biomerieux Inc 2023-01-11 Health serious FDA
Health · FDA · Recall #FDA-Z-0817-2023
ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218 Recall
Issued January 11, 2023 · Biomerieux Inc
In January 2023, Biomerieux Inc recalled the ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
What you should do
- 1 Stop using ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218 right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Biomerieux Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Biomerieux Inc
- Category
- Health
- Recall date
- January 11, 2023
- Units affected
- Not reported
- Sold at
- US Nationwide distribution.
- Recall number
- FDA-Z-0817-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Biomerieux Inc has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.